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ABSTRACT: Lipoarabinomannan (LAM) and arabinogalactan
(AG) are the two major mycobacterial cell wall (lipo)-
polysaccharides, which contain a structurally similar arabinan
domain that is highly branched and assembled in a stepwise
fashion by variety of arabinofuranosyltransferases (ArafT). In
addition to playing an essential role in mycobacterial physiology,
LAM and its biochemical precursor lipomannan possess potent
immunomodulatory activities that aﬀect the host immune
response. In the search of additional mycobacterial ArafTs that
participate in the synthesis of the arabinan segment of LAM, we
disrupted af tB (MSMEG_6400) in Mycobacterium smegmatis.
The deletion of chromosomal af tB locus could only be achieved in the presence of a rescue plasmid carrying a functional copy of
af tB, strongly suggesting that it is essential for the viability of M. smegmatis. Isolation and detailed structural characterization of a
LAM molecule derived from the conditional mutant deﬁcient in AftB revealed the absence of terminal β(1 → 2)-linked
arabinofuranosyl residues. Furthermore, we demonstrated that truncated LAM displays proinﬂammatory activity, which is due to
its ability to activate Toll-like receptor 2. All together, our results indicate that AftB is an essential mycobacterial ArafT that plays
a role in the synthesis of the arabinan domain of LAM.
Despite the existence of treatments for tuberculosis (TB),TB continues to represent a major healthcare challenge,
accounting for nearly 9 million new infections and over 1
million deaths each year.1 Indeed, this global health threat is
escalating, given the variable eﬃcacy of the vaccine strain BCG,
the increased susceptibility of HIV-infected individuals to TB,
and the increased prevalence of multi-drug-resistant (MDR)
and extensively drug-resistant (XDR) strains of Mycobacterium
tuberculosis, the causative agent of the disease.1 As current
treatments lose their eﬃcacy, it is vital that we address the
increasing health burden of TB by replenishing the drug
pipeline with new drugs, drug targets, and improved treatment
regimes.
The cell envelope of M. tuberculosis is unique in that it
contains a thick carbohydrate and lipid rich layer that accounts
for its inherent resistance to numerous drugs and contributes to
its persistence and virulence. This is due to the key cell
envelope structures, notably the mycolyl-arabinogalactan-
peptidoglycan complex (mAGP), lipomannan (LM), and
lipoarabinomannan (LAM). The latter glycolipids, in addition
to their structural roles, exhibit potent immunomodulatory
activities and thus are probably important modulators of the
host−pathogen interactions during the course of infection.
In mycobacteria, LM is composed of approximately 20−25
α(1→ 6) α-D-mannopyranosyl (Manp) residues connected in a
linear fashion and are anchored to the inner and outer
membrane via their phosphatidyl-myo-inositol (PI) unit.2,3 This
mannose core is further decorated with 7−10 singular α(1 →
2) Manp residues. The mature LM then serves as a precursor to
the formation of LAM where it is further glycosylated by large
arabinan domain consisting of approximately 55−70 Araf
residues in a linear α(1 → 5)-D-Araf fashion with 3,5-α-D-Araf
branches (Figure 1).4 Recent studies suggest that this single
arabinan chain is attached to the mannan core at the O-6
position of the mannosyl residue and not O-2 as previously
reported.5,6 Although, the arabinan structure of LAM is more
variable than that of AG, two types of highly branched and
conserved motifs remain. These are the tetra-arabinoside (β-D-
Araf(1 → 2)-α-D-Araf(1 → 5)-α-D-Araf(1 → 5)-α-D-Araf) and
hexa-arabinoside ([β-D-Araf(1 → 2)-α-D-Araf ]2-3,5-α-D-Araf(1
→ 5)-α-D-Araf) motifs, both of which end with a characteristic
disaccharide unit (Araf-β(1 → 2)-Araf-α(1 →.).4,5 The termini
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of the arabinan domain are completed with the capping motifs
that are species dependent. The fast growers, such as M.
smegmatis, are capped by phosphoinositide units (PILAM). The
slow growers including M. tuberculosis are capped with 2−3
mannose residues (Man-LAM), and some species, such as
Mycobacterium chelonae have uncapped LAM (AraLAM).5,7,8 In
addition, C. glutamicum, a closely related organism to M.
tuberculosis and a desired model organism to study
mycobacterial AG and LM assembly, produces LAM that
lacks a highly branched arabinan domain and contains single
Araf residues attached to the mannan core by AftE.9 As a result,
although the structure of LAM has been fairly well described,
understanding physiological functions and biological activities
of lipoglycans prove to be challenging.
Targeting the enzymes responsible for the synthesis and
assembly of the arabinan domains of AG and LAM continue to
present opportunities for new chemotherapeutics. Indeed, the
front-line anti-TB drug ethambutol targets the assembly of
these vital cell wall structures by inhibiting the embCAB
operon.10 Individual genetic disruption of embA, embB, and
embC in M. smegmatis revealed that both EmbA and EmB are
α(1 → 5) ArafT that play a key role in the synthesis of the
arabinan domain of AG, whereas EmbC is required exclusively
for the elongation of the arabinan domain of LAM.10,11
Recently identiﬁed α(1 → 6) ArafT, capable of utilizing
synthetic (1→ 6)-Manp disaccharide and trisaccaride acceptors
in vitro, was suggested to prime the mannan core. However,
further analysis is required to identify the enzyme responsible.6
Deletion studies in M. smegmatis identiﬁed ArafT with dual
function −AftC− that is responsible for the α-1,3-branching of
the linear arabinose polymers of AG and LAM.12,13 In vitro
assays using neoglycolipid acceptors and cell-free extracts from
M. smegmatis demonstrated that AftD was able to add α(1→ 3)
Araf residues to the linear α-1,5-linked acceptor, resulting in
branching of the linear arabinan. It was concluded that AftD
participates in the arabinan synthesis of both AG and LAM.14
Finally, the branched arabinose motif of LAM is further
modiﬁed to either a tetra-arabinoside or a hexa-arabinoside
motif by an unknown β(1 → 2) ArafT.
As several ArafT’s have a dual role and are involved in the
arabinan synthesis of both AG and LAM polysaccharides, we
investigated the potential role of AftB in LAM biosynthesis.
Our previous studies in Corynebacterium glutamicum identiﬁed
AftB as a nonessential ArafT responsible for the terminal β(1
→ 2) linkages at the nonreducing end of the arabinan domain
of AG.15 However, the disruption and essentiality of af tB in
Mycobacterium species or its essential role in LAM biosynthesis
has not been reported. Herein, we demonstrate the essentiality
of af tB in M. smegmatis using the conditional expression-
specialized transduction essentiality test (CESTET) and
analyzed the structure of LAM from the conditional M.
smegmatisΔaf tB::pMV306-af tB mutant. We have shown, for the
ﬁrst time, that AftB has a dual function and is responsible for
β(1 → 2)-linked Araf incorporation into LAM. Moreover, we
have analyzed the immunological properties of a LAM molecule
isolated from the af tB conditional mutant in order to shed the
light on the structure−function relationship between myco-
bacterial lipoglycans and host pattern recognition receptors
(PRRs), notably Toll-like receptor 2 (TLR2).
■ RESULTS AND DISCUSSION
Construction and Growth of the M. smegmatis aftB
Conditional Mutant. Our earlier studies demonstrated that
the nonessential AftB from C. glutamicum (Cg-AftB) adds the
terminal β(1 → 2)-linked Araf residues to the arabinan domain
of AG before its decoration with mycolic acids.15 In this study,
we investigated the potential role of AftB in the biosynthesis of
LAM in M. smegmatis. For this purpose, we constructed a
knockout phage phMSMEG6400 designed to replace the
chromosomal M. smegmatis af tB (Ms-af tB) with a hygromycin
resistance cassette (Figure 2a). Several attempts to obtain a Ms-
af tB null mutant were unsuccessful, suggesting that Ms-af tB,
unlike its homologue in C. glutamicum, is an essential gene.15
We then employed CESTET and generated a Ms-af tB
conditional mutant by transducing a merodiploid M.
smegmatis::pMV306-af tB strain containing a second, inducible
copy of af tB to yield M. smegmatisΔaf tB::pMV306-af tB.16 The
correct replacement of the native chromosomal copy of af tB
with a hygromycin cassette in the transductants was conﬁrmed
by Southern blot analysis (Figure 2b). In order to conﬁrm af tB
essentiality and to study the fate of the mycobacterial cells
depleted of AftB, we monitored the growth of M.
smegmatisΔaf tB::pMV306-af tB in liquid medium in the
presence and absence of acetamide over 28 h (Figure 2c).
Optical density (OD) measurements revealed normal growth
kinetics for the mutant strain grown in media containing
acetamide. However, cells cultured in the absence of inducer
showed a decrease in OD after 16 h of growth and cell lysis
after 28 h of incubation. This decrease in OD correlated with a
decrease in the number of CFUs (Figure 2c). Although, the
af tB homologue in C. glutamicum has been reported to be
nonessential,15 the failure to obtain a af tB null mutant in the
absence of second inducible copy of af tB, coupled with the
inability of M. smegmatis to grow in the media without
acetamide, an inducer that activates af tB expression, shows that
AftB is crucial for the viability of M. smegmatis. In addition,
Figure 1. Structural representation of the wild type lipoarabino-
mannan and the unknown arabinofuranosyltransferase investigated in
this study.
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previous studies employing high density mutagenesis studies
suggest that Rv3805c in M. tuberculosis is an essential gene.17 It
is reasonable to conclude that af tB is essential for M.
tuberculosis viability and therefore represents an attractive
drug target.
Initial Characterization of Lipoglycans Extracted from
the M. smegmatis aftB Conditional Mutant. Strains of M.
smegmatis, M. smegmatis::pMV306-af tB, and conditional M.
smegmatisΔaf tB::pMV306-af tB mutant grown in the presence
and absence of acetamide were examined for their ability to
synthesize LAM. Exponentially growing cultures including M.
smegmatisΔaf tB::pMV306-af tB depleted of AftB were labeled
with [1, 2-14C]-glucose for 10 h followed by lipoglycan
extraction. [14C]-LAM and [14C]-LM were proﬁled using
SDS-PAGE analysis and the lipoglycans revealed and quantiﬁed
by phosphorimaging (Figure 3a). Extracts from all strains
showed the presence of [14C]-LAM and [14C]-LM (Figure 3a).
Densitometry analysis revealed no signiﬁcant diﬀerence in
lipoglycan proﬁles extracted from diﬀerent strains. Subse-
quently, [14C]-lipoglycans were assessed for the reactivity with
an anti-AraLAM (α-AraLAM) monoclonal antibody (mAb,
F30-5), which recognizes the terminal arabinan branches of
LAM.18,19 All lipoglycan preparations reacted with the antibody
F30-5, with an exception of LAM isolated from the M.
smegmatisΔaf tB::pMV306-af tB depleted of AftB (Figure 3b).
These results strongly indicate that AftB is involved in the
synthesis of the nonreducing end of arabinan domain of LAM
in M. smegmatis.
Structural Characterization of LAM Isolated from the
M. smegmatis aftB Conditional Mutant. One of the
disadvantages in generating conditional mutants by employing
Figure 2. Generation of a conditional af tB mutant in M. smegmatis. (a)
A map of the af tB region in the parental M. smegmatis strain, its
corresponding region in the conditional M. smegmatisΔaf tB::pMV306-
af tB mutant and merodiploid strain; res, resolvase site; hyg,
hygromycin resistance gene from Streptomyces hygroscopicus; sacB,
sucrose counter-selectable gene from Bacillus subtilis. Digoxigenin-
labeled probes were derived from ∼1 kb upstream and downstream
ﬂanking sequences that were used to construct the knockout plasmid
and are indicated by thick lines with square ends. SacI-digested bands
expected in a Southern blot are indicated in I, II, III, and *. (b) The
Southern blot of SacI-digested genomic DNA from the merodiploid
and conditional af tB mutant with expected bands I, II, and III. The
asterisk (*) indicates a band appearing as a result of a second af tB
copy integration into mycobacterial chromosome. Representative lanes
are from the same Southern blot and are grouped next to each other
for clarity. (c) Log CFU obtained from cultures of M. smegmatisΔaf tB
pMV306-af tB grown with and without acetamide (Ac). Log10 CFU
values were calculated from diﬀerent dilutions at diﬀerent time points
from a single experiment. The images on the right show cultures after
28 h of growth in the presence and absence of Ac. Results are mean ±
SD from n = 3 colonies per strain and are from one representative of
two independent experiments.
Figure 3. Lipoglycan proﬁles of M. smegmatis, M. smegmatis pMV306-
af tB, and M. smegmatisΔaf tB pMV306-af tB strains grown with and
without acetamide. (a) Equivalent aliquots of [14C]-lipoglycans
(20,000 cpm) were analyzed using SDS-PAGE and visualized by
phosphorimaging. The three major bands represented by Ms-LAM,
Ms-LM and Ms-PIMs are indicated. The protein molecular weight
standards are provided on the left for comparison. (b) Equivalent
aliquots (50 000 cpm) of [14C]-lipoglycans from each strain were
immunoblotted with α-AraLAM antibody F30-5 that recognizes the
branches of the arabinan domain of LAM. The major band represented
by Ms-LAM is indicated. The protein molecular weight standards are
provided on the left for comparison.
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CESTET is the restricted time scale where cells have to be
cultured in the absence of acetamide long enough to deplete
the intracellular protein of interest but short enough not to
yield persister cells, which results in a modest yield of cell mass.
In order to further analyze the diﬀerent LAM preparations by
NMR spectroscopy and improve the carbon signal intensity due
to poor cell yield, we labeled M. smegmatisΔaf tB pMV306-af tB
cultured in the presence and absence of acetamide with [13C]-
glucose for 10 h, followed by lipoglycan extraction. Puriﬁed
[13C]-lipoglycans were recovered from the crude extracts by
hydrophobic and gel exclusion chromatography before
subjecting samples to 1H−13C HSQC analysis. On the basis
of our earlier studies with mycobacterial LAM13 and previously
published work,20,21 we assigned the proton and carbon
resonances of the diﬀerent spin systems using 1H−13C
HSQC experiments. The 13C resonances at δ101.1 ppm and
δ102.3 ppm correlating to protons at δ5.11 ppm and δ4.91 ppm
were assigned as 2,6-α-Manp and 6-α-Manp linkages,
respectively (Figure 4a,b). The resonance at δ105.0 ppm,
which correlated to an anomeric proton at δ5.04 ppm, was
designated as t-α-Manp. As expected, the resonances associated
with the mannan core (2,6-α-Manp, 6-α-Manp, and t-α-Manp)
remained unaﬀected by the disruption of AftB activity and as a
result were visible in both 1H−13C HSQC spectra (Figure
4a,b). The resonances associated with the arabinan domain,
however, were notably more complex in the spectra of LAM
isolated from the M. smegmatisΔaf tB::pMV306-af tB grown in
the presence of acetamide (Figure 4a) than compared to the
resonances of LAM extracted from M. smegmati-
sΔaf tB::pMV306-af tB grown in the absence of the inducer
(Figure 4b). Several spin systems with 13C resonances at δ110.0
ppm and δ110.4 ppm were assigned to anomeric protons at
δ5.16 ppm and δ5.08 ppm, respectively, and designated as 5-α-
Araf in diﬀerent chemical environments. The 3,5-α-Araf
residues corresponded to δ110.4 ppm and were assigned to
protons at δ5.09 ppm. The 2,3-α-Araf and 2,5-α-Araf linkages
corresponded to δ108.4 ppm and δ108.6 ppm with protons at
δ5.24 ppm and δ5.17 ppm, respectively (Figure 4a). Finally, the
13C resonance at δ103.5 ppm was designated to δ 5.14 ppm as
the t-β-Araf linkage (Figure 4a). Most importantly, only 5-α-
Araf and 3,5-α-Araf residues were conserved in the LAM of M.
smegmatisΔaf tB::pMV306-af tB depleted of AftB, but 2,3-α-
Araf, 2,5-α-Araf, and t-β-Araf linkages were absent due to the
loss of β(1 → 2) linkages (Figure 4a,b). The 1H−13C HSQC
experiments conﬁrmed that AftB acts as a β(1 → 2) ArafT in
the biosynthesis of LAM in M. smegmatis. The full HSQC
spectra are available in the Supporting Information (Supporting
Figure 1). Further chemical characterization, such as gas
chromatography analysis, could provide accurate glycosyl
composition of the truncated LAM; however due to the nature
of the conditional mutant and a modest yield of cell mass
generated, such analysis has proved to be extremely diﬃcult to
perform.
Analysis of Toll-like Receptor 2 Activation and
Cytokine Production by Truncated LAM. Both LM and
LAM display immunoregulatory and anti-inﬂammatory proper-
ties that aﬀect the host immune response.22,23 A family of
pattern recognition receptors, named TLR2 in association with
TLR1 and TLR6, detect a wide range of ligands including
mycobacterial LAM. Studies have demonstrated that the lipidic
part of the molecule is required for its activity, whereas the
glycosidic moiety was shown to contribute by directly
controlling the extent of this activity.24 Thus, we explored the
capacity of truncated LAM extracted from the conditional M.
smegmatisΔaf tB::pMV306-af tB mutant depleted of AftB to
induce TLR2-dependent innate immune responses. Previous
studies demonstrated that a positive relation exists between the
length of the mannan chain and the ability of the lipoglycan to
activate TLR2.24 Lipoglycans with accessible long mannan
domains, such as LM, were shown to be potent inducers of
TLR2, whereas LAM molecules were poor activators of the
TLR2 signaling due to their large arabinan domain somehow
obstructing the availability of the mannan chain.13,25,26 Crude
lipoglycan preparations extracted from M. smegmati-
sΔaf tB::pMV306-af tB, cultured in the presence and absence
of acetamide, were subsequently subjected to hydrophobic and
size exclusion chromatography to yield pure LAM fractions
(Figure 5a,b).27,28 Earlier studies have reported that some of
the LAM preparation from M. smegmatis may have been
contaminated with lipopeptides and as a result had an immune
stimulatory activity.13,24 Therefore, we have assessed both
puriﬁed truncated and full-length LAM fractions for their
activity on HEK293 cells that stably express human TLR4,
which is the receptor for bacterial lipopolysaccharide (LPS) and
lipid A.29 Cells were incubated with LPS, which served as a
positive control, at concentrations ranging from 0.01 ng mL−1
to 1 μg mL−1 and both LAM fractions at concentrations
ranging from 0.5 ng mL−1 to 10 μg mL−1. In the presence of
Figure 4. Expanded region (δ 1H: 4.80−5.30, δ 13C: 100−112) of the
two-dimensional 1H−13C HSQC spectra in D2O at 313 K of M.
smegmatis LAM extracted from the af tB conditional mutant in the
presence (a) and absence (b) of AftB.
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LPS, a dose-dependent eﬀect was observed, whereas HEK293-
TLR4 cells stimulated with the puriﬁed full-length and
truncated LAM resulted in similar results to those of the
noninduced cells (Figure 6a). Therefore, we have concluded
that the isolated LAM fractions were devoid of lipopeptide
contamination. Subsequently, a derivative of HEK293 cells that
stably expresses human TLR2 along with a NF-κB-inducible
reporter system were incubated with full-length and truncated
LAM extracted from M. smegmatisΔaf tB::pMV306-af tB grown
in the presence and absence of acetamide, respectively, at
concentrations ranging from 0.5 ng mL−1 to 10 μg mL−1. The
synthetic Pam3CSK4 lipopeptide was used as a positive control
of TLR2 activation at concentrations ranging from 0.01 ng
mL−1 to 1 μg mL−1. As shown in Figure 6b, both puriﬁed LAM
molecules induced NF-κB activation in a dose-dependent
fashion with the truncated LAM exhibiting a stronger TLR2
activation than compared to the full length LAM. A similar
dose-dependent eﬀect was observed when human monocyte/
macrophage THP-1 cells, which also stably express a NF-κB-
inducible reporter system, were incubated with full length
LAM, truncated LAM, and Pam3CSK4 ligands (Figure 6c). As
activation of TLR2 results in production of various cytokines
and ultimately regulates the adaptive immunity, TLR2-depend-
ent IL-8 production was measured in the supernatants of
stimulated THP-1 cells (Figure 6d). Cells were incubated with
full length and truncated LAM at concentrations of 2 μg mL−1
and 10 μg mL−1 and a positive reference ligand Pam3CSK4 at
concentrations of 100 ng mL−1 and 1 μg mL−1. The TLR2
dependent activation of NF-κB and subsequently the
production of IL-8 by truncated LAM was signiﬁcantly stronger
than compared to the one induced by full-length LAM (Figure
6d). The potency of truncated LAM to induce TLR2 response
in both HEK293 and THP-1 cells suggests that a more exposed
mannan chain may allow TLR2 to more readily recognize the
lipoglycan. This is also consistent with the previous reports.13
In addition, we assessed if the induction of NF-κB and
production of IL-8 is a direct result of TLR2 activation by using
an anti-TLR2 antibody in THP-1 cells (Figures 6e, 6f). Cells
were preincubated with the anti-TLR2 or isotype control
antibodies (10 μg mL−1) for 30 min at 37 °C followed by
incubation with full length LAM (5 μg mL−1), truncated LAM
(5 μg mL−1), or Pam3CSK4 lipopeptide (1 μg mL
−1). Both full
length and truncated LAM induced activation of NF-κB (Figure
6e) and as a result production of IL-8 (Figure 6f) that was
almost completely abolished by an anti-TLR2 antibody, thus
demonstrating signaling through the TLR2.
A substantial number of biological activities have been
associated with phosphatidyl-myo-inositol-based glycolipids,
notably LM and LAM.22,23,30 LM, a precursor of LAM, is
composed of the conserved mannosyl-phosphate inositol
anchor and mannan core. It was demonstrated to carry a dual
modulatory function where it acts as a strong agonist for TLR2-
dependent stimulation as well as exhibits TLR2 independent
inhibition of cell activation and proinﬂammatory cytokine
synthesis in murine primary macrophages.25 Further studies
revealed that the degree of LM acylation plays an important
role in pro- and anti- inﬂammatory properties31,32 whereas its
mannan chain directly determines the lipoglycan activity.24
Speciﬁcally, the activity of lipoglycans seemed to increase with
the number of Manp units composing the mannan core.
Interestingly, mycobacterial LAMs have been shown to be poor
agonists of TLR2 despite containing the LM glycosidic moiety.
It is unclear how, but the large arabinan domain in LAM
perturbs the biological activity of the mannan core. This was
further conﬁrmed by the chemical degradation of the arabinan
domain of LAM and the regain of proinﬂammatory proper-
ties.26 The data presented here are in agreement with these
ﬁndings as the truncated LAM isolated from the conditional
af tB mutant demonstrated an increase in TLR2-dependent
proinﬂammatory activity compared to the full-length LAM. It
was suggested that the arabinan domain may exert its inhibitory
eﬀect by steric hindrance, which prevents interaction between
TLR2 and the underlying mannan domain.26 The arrangement
of the arabinofuranose residues in LAM is largely dependent on
the ﬂexibility of the glycosidic linkages and puckering of the
rings. It is known that ring puckering along with the more rigid
β(1 → 2) linkages promote water mediated hydrogen bonding
between diﬀerent arabinofuranose residues. A structural study
using fragments of the nonreducing termini of LAM and a
murine antibody CS-35Fab has suggested that such hydrogen
bonding between the arabinofuranose rings might contribute to
the stabilization and orientation of the arabinan component of
LAM.33 Therefore, we hypothesize that removal of the terminal
β(1 → 2) linkages can lead to a decrease in the propensity of
hydrogen bonding and subsequently to a less organized and
structurally compact arabinan domain as well as oﬀer additional
ﬂexibility. This in turn can result in a more exposed “bioactive”
mannan core. Further investigation is required to fully
understand arabinan’s role of LAM in relation to TLR2
activation.26
■ METHODS
Plasmid Construction. The 1938 bp coding region af tB
(MSMEG_6400) was ampliﬁed by PCR from M. smegmatis mc2155
Figure 5. LAM puriﬁcation proﬁles of M. smegmatisΔaf tB pMV306-
af tB grown with (a) and without (b) acetamide by gel exclusion
chromatography. Eluted samples were analyzed using SDS-PAGE and
visualized by Pro-Q emerald glycoprotein stain. The three major bands
represented by Ms-LAM, Ms-LM, and Ms-PIMs are indicated. The
protein molecular weight standards are provided on the left for
comparison. The indicated fractions that contained pure LAM
lipoglycan were pooled, extensively dialyzed in water, and dried.
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genomic DNA using the primer pair (restriction sites underlined): 5′-
GAT CGA TCG GAT CCG TGC GCA TCA GCC TGT GGC-3′
and 5′-GAT CGA TCA TCG ATC TAC GGT CCC GTT GCC
GGC-3′. A single copy integrating plasmid pMV306-af tB was
generated by ligating a 2.6 kb inducible acetamide promoter digested
with XbaI-BamHI and a 1.9 kb af tB digested with BamHI-ClaI into
pMV306 digested with XbaI-ClaI resulting in a pMV306 construct
containing af tB gene cloned downstream of the acetamide promoter.
The merodiploid strain was generated by electroporation of M.
smegmatis with pMV306-af tB and selecting for kanamycin resistant
colonies.
Generation of ΔaftB Conditional Mutant in M. smegmatis.
Approximately 1 kb upstream and downstream, ﬂanking sequences of
MSMEG_6400 (af tB) were PCR ampliﬁed from M. smegmatis mc2155
genomic DNA using the primer pairs: MS6400LL (5′-TTT TTT TTC
CAT AAA TTG GGA GTT ACA CCA GCA GCT ACC-3′) and
MS6400LR (5′-TTT TTT TTC CAT TTC TTG GAC CAG CAC
ACC ATC ATC C-3′) as well as MS6400RL (5′-TTT TTT TTC
CAT AGA TTG GAT GGG CAT GCT GGG CAT GAA CG-3′) and
MSMEG6400RR (5′-TTT TTT TTC CAT CTT TTG GCA CCG
AGA TGC CCG AGT TGT AG-3′). Following restriction digestion of
the primer incorporated Van91I sites, the PCR fragments were cloned
into Van91I-digested p0004S to yield the plasmid pΔMSMEG6400.
The resultant plasmid was then packaged into the temperature
sensitive phage phAE159 as described previously34 to yield the
knockout phage phΔMSMEG6400. Specialized transduction was
performed as described earlier,34 except that the host strain was the
merodiploid strain and half of the transduction mix was spread on TSB
agar plates containing kanamycin, hygromycin, and 0.2% (w/v)
acetamide while the other half was spread on plates lacking acetamide.
Deletion of the af tB gene was conﬁrmed using Southern blot analysis.
Conditional Depletion of AftB. Strains to be tested were grown
in either TSB or minimal medium supplemented with 0.05% (v/v)
Tween-80 and 0.2% (w/v) acetamide to an OD 600 nm of 0.5. Cells
were washed twice with media to remove traces of acetamide and
resuspended in the original volume of appropriate media. Culture was
used as a 20% inoculum in minimal media and grown for 12 h to
deplete intracellular AftB. The depleted subculture served as inoculum
(5%) for cultures with or without 0.2% (w/v) acetamide. Aliquots
were taken and labeled with either [1, 2-14C]-glucose 1 μCi mL−1 or
[13C6]-glucose for 10 h. Cells were harvested, washed with phosphate
buﬀered saline, and dried.
Cell Stimulation Assays. For stimulation assays, HEK293 and
THP-1 cells were plated at 50 000 cells per well. Cells were stimulated
with LAM at 0.5 ng mL−1 to 10 μg mL−1 in a ﬁnal volume of 200 μL.
Nonstimulated cells and cells stimulated with Pam3CSK4 (InvivoGen)
or LPS (InvivoGen) served as negative and positive controls,
respectively. Alkaline phosphatase activity was measured after 16−18
h by mixing 20 μL of the culture supernatant and 180 μL of Quanti-
BlueTM, reading absorbance at OD 630 nm. To investigate TLR2
dependence, THP-1 cells were preincubated for 30 min at 37 °C with
5 or 10 μg mL−1 of anti-TLR2 monoclonal antibody (clone T2.5,
Figure 6. Immune response proﬁles elicited by LAM extracted from conditional af tB mutant cultured in the presence and absence of acetamide. (a)
TLR4-dependent NF-κB activity by human HEK293-TLR4 cell line in response to the lipoglycans. (b) TLR2-dependent NF-κB activity by human
HEK293-TLR2 cell line in response to the lipoglycans. TLR2-dependent NF-κB (c) activation and IL-8 (d) production by human monocyte/
macrophage THP1 cell line in response to lipoglycans. TLR2-dependent NF-κB (e) activation and IL-8 (f) production by human THP-1 cells in
response to lipoglycans were tested using blocking antibody anti-TLR-2. Results are mean ± SD from n = 2 (a−c, e) or n = 3 (d, f) and are from one
representative of two (d, f) or three (a−c, e) independent experiments. The ×10 means that the concentration of cytokine detected is ampliﬁed 10-
fold. *< 0.05; n.i., not induced.
ACS Chemical Biology Articles
DOI: 10.1021/acschembio.6b00898
ACS Chem. Biol. XXXX, XXX, XXX−XXX
F
InvivoGen, mab-mtlr2, lot # MT2-37-01) or isotype control (IgG1,
eBioscience, 16-4714−85, lot # 4295108).
Cytokine ELISA. Culture supernatants from THP-1 cells were
harvested and assayed for IL-8 cytokine production using
commercially available ELISA kit and according to the manufacturer’s
instructions (Ready Set-Go ELISA kits, eBioscience).
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